Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Spot On Sciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Spot On Sciences

Spot On Sciences

Pre-Seed

Spot On Sciences, Inc. is a medical device company innovating in biological fluid sample collection and storage, aiming to simplify processes and reduce costs.

HQ
San Francisco, CA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Spot On Sciences, Inc., founded in San Francisco, is a medical device company focused on revolutionizing the collection and storage of biological fluid samples. Their core mission is to simplify and enhance the processes of biospecimen sampling, making it more accessible and cost-effective. The company’s flagship product, HemaSpot™, allows for easy blood sample collection and storage for dried blood spot (DBS) testing. Spot On Sciences targets the global market for in vitro diagnostics, which sees over 20 billion blood tests annually.

Notable affiliated individuals include the company's founders and key investors who have supported its innovative vision. Spot On Sciences has achieved significant milestones, including the successful development and commercialization of HemaSpot™. Their impact is marked by improved sample quality and streamlined logistics in biospecimen handling, benefiting both healthcare providers and patients worldwide.

Spot On Sciences - Similar Companies

Babson Diagnostics logo

Babson Diagnostics

babsondx.com

Sedia Biosciences logo

Sedia Biosciences

sediabio.com

YourBio Health logo

YourBio Health

yourbiohealth.com

Abogen logo

Abogen

OmniVis logo

OmniVis

Sanguine logo

Sanguine

sanguinebio.com

eGlint logo

eGlint

DotLab logo

DotLab

dotlab.com

BioInspire Technologies logo

BioInspire Technologies

SynapDx logo

SynapDx

Blood Cell Storage logo

Blood Cell Storage

safesens.com

BioAmp diagnostics logo

BioAmp diagnostics

bioampdx.com

PreDxion Bio logo

PreDxion Bio

predxionbio.com

NKA Bio logo

NKA Bio

nkabio.com

Aperture Bio logo

Aperture Bio

aperture.bio

Spot On Sciences - Quick Facts

Who are Spot On Sciences' competitors?

Companies similar to Spot On Sciences include Babson Diagnostics, Sedia Biosciences, YourBio Health and Abogen.

When was Spot On Sciences founded?

Spot On Sciences was founded in 2010.

Where is Spot On Sciences' headquarters located?

Spot On Sciences' headquarters is located in San Francisco, CA, US.

When was Spot On Sciences' last funding round?

Spot On Sciences' most recent funding round was for $750k (USD) in June 2014.

How much has Spot On Sciences raised to-date?

As of Jun 16, 2014, Spot On Sciences has raised a total of $750k (USD).

How many employees does Spot On Sciences have?

Spot On Sciences has 11 employees as of Feb 4, 2024.

Spot On Sciences - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Biotech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified